Skip to content

Clinical trials

Major Depressive Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Country / region: Australia Clear all

66 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20044
20051
20062
20075
20085
20095
20103
20114
20122
20133
20144
20161
20171
20181
20191
20201
20213
20223
20234
20241
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed43
Recruiting8
Unknown status6
Terminated3
Not yet recruiting2
Withdrawn1
Approved for marketing1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The University of New South Wales12
Eli Lilly and Company6
Alkermes, Inc.4
The Alfred4
Bayside Health3
GlaxoSmithKline3
AstraZeneca2
Baker Heart and Diabetes Institute2
Cybin IRL Limited2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder66
Depressive Disorder12
Mood Disorders11
Depressive Disorder, Treatment-Resistant6
Mental Disorders4
Anxiety Disorders3
Bipolar Disorder3
Dysthymic Disorder2
Alcoholism1
Anhedonia1

Trials

Showing 51 to 66 of 66. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.